While systolic cardiomyocyte function is preserved, diastolic myocyte function and recovery from acidosis are impaired in CaMKIIδ-KO mice.
While systolic cardiomyocyte function is preserved, diastolic myocyte function and recovery from acidosis are impaired in CaMKIIδ-KO mice.
复制标题
DOI:
10.1016/j.yjmcc.2013.02.014
复制
发表时间:
2013-06
影响因子:
5
通讯作者:
Maier, Lars S.
中科院分区:
文献类型:
--
作者:
Neef, Stefan;Sag, Can M.;Daut, Maria;Baeumer, Henrik;Grefe, Clemens;El-Armouche, Ali;DeSantiago, Jaime;Pereira, Laetitia;Bers, Donald M.;Backs, Johannes;Maier, Lars S.
CaMKII contributes to impaired contractility in heart failure by inducing SR Ca2+-leak. CaMKII-inhibition in the heart was suggested to be a novel therapeutic principle. Different CaMKII isoforms exist. Specifically targeting CaMKIIδ, the dominant isoform in the heart, could be of therapeutic potential without impairing other CaMKII isoforms. We investigated whether cardiomyocyte function is affected by isoform-specific knockout (KO) of CaMKIIδ under basal conditions and upon stress, i.e. upon ß-adrenergic stimulation and during acidosis. Systolic cardiac function was largely preserved in the KO in vivo (echocardiography) corresponding to unchanged Ca2+-transient amplitudes and isolated myocyte contractility in vitro. CaMKII activity was dramatically reduced while phosphatase-1 inhibitor-1 was significantly increased. Surprisingly, while diastolic Ca2+-elimination was slower in KO most likely due to decreased phospholamban Thr-17 phosphorylation, frequency-dependent acceleration of relaxation was still present. Despite decreased SR Ca2+-reuptake at lower frequencies, SR Ca2+-content was not diminished, which might be due to reduced diastolic SR Ca2+-loss in the KO as a consequence of lower RyR Ser-2815 phosphorylation. Challenging KO myocytes with isoproterenol showed intact inotropic and lusitropic responses. During acidosis, SR Ca2+-reuptake and SR Ca2+-loading were significantly impaired in KO, resulting in an inability to maintain systolic Ca2+-transients during acidosis and impaired recovery. Inhibition of CaMKIIδ appears to be safe under basal physiologic conditions. Specific conditions exist (e.g. during acidosis) under which CaMKII-inhibition might not be helpful or even detrimental. These conditions will have to be more clearly defined before CaMKII inhibition is used therapeutically.
登录
查看更多内容
影响因子:
37.8
作者:
Toischer K;Rokita AG;Unsöld B;Zhu W;Kararigas G;Sossalla S;Reuter SP;Becker A;Teucher N;Seidler T;Grebe C;Preuss L;Gupta SN;Schmidt K;Lehnart SE;Krüger M;Linke WA;Backs J;Regitz-Zagrosek V;Schäfer K;Field LJ;Maier LS;Hasenfuss G
通讯作者:
Hasenfuss G
影响因子:
56.9
作者:
De Koninck, P;Schulman, H
通讯作者:
Schulman, H
影响因子:
5.5
作者:
Ronkainen, Jarkko J.;Hanninen, Sandra L.;Tavi, Pasi
通讯作者:
Tavi, Pasi
DOI:
10.1016/j.ddmec.2010.07.005
发表时间:
2010-01-01
期刊:
Drug discovery today. Disease mechanisms
影响因子:
--
作者:
Schulman, Howard;Anderson, Mark E
通讯作者:
Anderson, Mark E
影响因子:
5
作者:
DeSantiago, J;Maier, LS;Bers, DM
通讯作者:
Bers, DM